Selective modulation of PPARγ activity can lower plasma glucose without typical thiazolidinedione side-effects in patients with Type 2 diabetes

Fredrick L. Dunn, Linda S. Higgins, Jill Fredrickson, Alex M. Depaoli

Research output: Contribution to journalArticlepeer-review

69 Scopus citations

Fingerprint

Dive into the research topics of 'Selective modulation of PPARγ activity can lower plasma glucose without typical thiazolidinedione side-effects in patients with Type 2 diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences